基于肝脏剪切波速评价恩替卡韦联合扶正化瘀胶囊治疗慢性乙型肝炎肝纤维化疗效的研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R512.6;R575.2

基金项目:

广东省中医药局科研项目(20191299);广东省名中医传承工作室建设项目(粤中医办函〔2020〕1号);广东省中医药局名中医师承 项目(粤中医函〔2015〕20号)


Evaluation of Clinical Study of Entecavir Combined with Fuzheng Huayu Capsules for Liver Fibrosis Induced by Chronic Hepatitis B Based on Liver Shear Wave Velocity
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探究应用肝脏剪切波速评价恩替卡韦(ETV) 联合扶正化瘀胶囊治疗慢性乙型肝 炎(CHB) 肝纤维化的临床疗效。方法:选取CHB 肝纤维化伴肝硬化患者214 例,其中符合抗病毒治疗指征 的186 例,根据不同治疗方法分为试验组116 例和对照组70 例;其余未达抗病毒治疗指征28 例设为未干预组 作对照研究。对照组给予马来酸恩替卡韦片治疗,试验组在对照组基础给予扶正化瘀胶囊治疗。比较治疗前后 行肝脏剪切波速、肝功能指标[丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆红素(TBil)、 白蛋白(Alb)] 及HBV-DNA 转阴率。结果:治疗后,2 组ALT、AST 水平较治疗前降低,差异均有统计学 意义(P<0.05);2 组TBil、Alb 水平治疗前后比较差异无统计学意义(P>0.05)。治疗后,2 组ALT、AST、 TBil、Alb 水平比较,差异无统计学意义(P>0.05)。治疗期间,2 组HBV-DNA 转阴率随着时间延长逐渐增 加,试验组转阴率总体略高于对照组,但组间差异无统计学意义(P>0.05)。治疗前,试验组及对照组剪切波 速均较未干预组显著增高,差异有统计学意义(P<0.05);试验组与对照组比较,差异无统计学意义(P> 0.05)。治疗后,试验组、对照组剪切波速均较治疗前下降(P<0.05),且试验组剪切波速较对照组下降更显 著(P<0.05)。结论:肝脏剪切波速可以用来对CHB 肝纤维化疗效进行评估,扶正化瘀胶囊联合ETV 治疗可 有效改善CHB 肝纤维化,降低肝脏剪切波速数值。

    Abstract:

    Abstract: Objective: To discuss the application of liver shear wave velocity in evaluating the clinical effect of Entecavir (ETV) combined with Fuzheng Huayu Capsules on liver fibrosis in chronic hepatitis B (CHB). Methods:A total of 214 patients with CHB liver fibrosis and hepatic sclerosis were selected,among which 186 patients who met the indicators of antivirus therapy were divided into the trial group and the control group according to different treatment methods,with 116 and 70 cases in each group respectively; the remaining 28 cases which did not meet the indicators of antivirus therapy were set as non-intervention group for control study. The control group was treated with Entecavir Tablets, and the trial group was additionally treated with Fuzheng Huayu Capsules based on the treatment of the control group. Before and after treatment, the liver shear wave velocity and indexes of liver function, including alanine aminotransferase (ALT) , total bilirubin (TBil) and albumin (Alb) , were compared , and the HBV-DNA seroconversion rates were detected. Results: There was no significant difference being found in the comparisons of levels of TBil and Alb in the two groups before and after treatment (P>0.05). After treatment,the levels of ALT,AST,TBil and Alb were compared between the two groups,there being no significance in the difference (P>0.05). During treatment,the HBV-DNA negative conversion rates in the two groups were gradually increased with the prolongation of treatment time,and the negative conversion rate in the trial group was slightly higher than that in the control group on the whole, but there was no significant difference being found in the comparison of negative conversion rate between the two groups (P>0.05). Before treatment, the shear wave velocity in the trial group and the control group were significantly increased when compared with those in the non- intervention group, the difference being significant (P<0.05); there was no significant difference being found in the comparison of shear wave velocity between the trial group and the control group (P>0.05). After treatment,the shear wave velocity in the trial group and the control group were decreased when compared with those before treatment (P< 0.05), and the decrease of shear wave velocity in the trial group was more significant than that in the control group (P<0.05). Conclusion:The liver shear wave velocity can be applied to evaluate the curative effect on CHB liver fibrosis,and the therapy of Fuzheng Huayu Capsules combined with ETV can effectively improve the CHB liver fibrosis and decrease the value of liver shear wave velocity.

    参考文献
    相似文献
    引证文献
引用本文

胡萌,张冬,卓永祥,李丹,王文辉,田广俊.基于肝脏剪切波速评价恩替卡韦联合扶正化瘀胶囊治疗慢性乙型肝炎肝纤维化疗效的研究[J].新中医,2023,55(8):82-85

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-25
  • 出版日期:
文章二维码